Related Experiment Video
Updated: Nov 26, 2025

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats
Published on: June 28, 2019
Fractional flow reserve guided versus angiographic guided surgical revascularization: A meta-analysis
Francesco Bruno1, Fabrizio D'Ascenzo1, Giorgio Marengo1
1Division of Cardiology, Department of Cardiovascular and Thoracic, Città della Salute e della Scienza Hospital and University of Turin, Turin, Italy.
Insights
Fraction Flow Reserve (FFR) guided Coronary Artery Bypass Grafting (CABG) reduces anastomoses and on-pump procedures. This approach does not increase Major Adverse Cardiac Events (MACE) risk but also does not reduce graft occlusion.
Area of Science:
- Cardiovascular Surgery
- Interventional Cardiology
- Medical Technology Assessment
Background:
- The clinical benefits of Fraction Flow Reserve (FFR) guided Coronary Artery Bypass Grafting (CABG) require further establishment.
- Current evidence comparing FFR-guided versus angiography-guided CABG is limited.
Purpose of the Study:
- To evaluate the clinical outcomes of FFR-guided CABG compared to traditional angiography-guided CABG.
- To assess the impact of FFR guidance on Major Adverse Cardiac Events (MACE) and procedural characteristics.
Main Methods:
- A systematic review and meta-analysis of randomized controlled trials (RCTs) and observational studies.
- Inclusion criteria encompassed studies with multivariable adjustment comparing FFR-guided and angiography-guided CABG.
- Primary endpoint was MACE; secondary endpoints included mortality, myocardial infarction, total vessel revascularization (TVR), anastomoses, on-pump procedures, and graft occlusion.
Main Results:
- Four studies (2 RCTs, 2 observational) with 983 patients were analyzed.
- No significant difference in MACE, all-cause death, myocardial infarction, or TVR between FFR-guided and angiography-guided CABG.
- FFR-guided CABG was associated with a reduction in on-pump procedures and the number of anastomoses.
Conclusions:
- FFR-guided CABG effectively reduces procedural complexity (fewer anastomoses, on-pump procedures) without compromising safety regarding MACE.
- The study did not find evidence of reduced graft occlusion with FFR-guided CABG.
- Further research may be warranted to fully elucidate long-term clinical benefits.
Background:
Clinical benefits of FFR (Fraction Flow Reserve) driven CABG (Coronary Artery Bypass Graft) remain to be established.
Methods:
All randomized controlled trials (RCTs) and observational studies with multivariable adjustement were included. MACE (Major Adverse Cardiac Events) was the primary end point, while its single components (death, myocardial infarction, and total vessel revascularization [TVR]) along with number of anastomoses, on pump procedures and graft occlusion at angiographic follow-up were the secondary ones. Each analysis was stratified for RCTs versus observational studies.
Results:
Four studies (two RCTs and two observational) were included, enrolling 983 patients, 542 angio-guided and 441 FFR-guided. Mean age was 68.45 years, 79% male, with a mean EuroSCORE I of 2.7. Coronary lesions were located in 37% of patients in the left anterior descending artery, 32% in the circumflex artery, and 26% in the right coronary artery. After a mean follow-up of 40 months, risk of MACE did not differ (OR 0.86 [0.63-1.18]) as that of all cause death (OR 0.86 [0.59-1.25]), MI (OR 0.57 [0.30-1.11]) and TVR (OR 1.10 [0.65-1.85]). FFR-driven CABG reduced on-pump procedures (OR 0.58 [0.35-0.93]) and number of anastomoses (-0.40 [-0.80: -0.01]) while incidence of graft occlusion at follow-up did not differ (OR 0.59 [0.30-1.15], all CI 95%).
Conclusion:
Fraction flow reserve driven CABG reduced the number of anastomoses and of on-pump procedures without increasing risk of MACE and without reducing graft occlusion at angiographic follow-up. ID CRD42020211945.
More Related Videos
05:07Author Spotlight: Improved Localization and Monitoring of Coronary Flow Reserve Using Modified PLAX View in Mice
Published on: August 25, 2023
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020